I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 16 studies | 24% ± 7% | |
| fibroblast | 14 studies | 23% ± 6% | |
| glutamatergic neuron | 9 studies | 46% ± 20% | |
| adipocyte | 9 studies | 32% ± 6% | |
| basal cell | 9 studies | 27% ± 11% | |
| oligodendrocyte | 9 studies | 30% ± 11% | |
| GABAergic neuron | 7 studies | 39% ± 19% | |
| oligodendrocyte precursor cell | 7 studies | 30% ± 13% | |
| astrocyte | 7 studies | 32% ± 14% | |
| epithelial cell | 6 studies | 35% ± 16% | |
| pericyte | 6 studies | 23% ± 7% | |
| type II pneumocyte | 6 studies | 25% ± 6% | |
| smooth muscle cell | 6 studies | 20% ± 2% | |
| neuron | 5 studies | 34% ± 14% | |
| type I pneumocyte | 5 studies | 22% ± 5% | |
| macrophage | 5 studies | 24% ± 8% | |
| interneuron | 5 studies | 45% ± 24% | |
| microglial cell | 5 studies | 27% ± 8% | |
| naive B cell | 4 studies | 18% ± 2% | |
| mesothelial cell | 4 studies | 29% ± 12% | |
| vein endothelial cell | 4 studies | 25% ± 11% | |
| ciliated cell | 4 studies | 25% ± 8% | |
| retinal cone cell | 4 studies | 33% ± 14% | |
| abnormal cell | 4 studies | 26% ± 13% | |
| endothelial cell of lymphatic vessel | 4 studies | 25% ± 4% | |
| endothelial cell of vascular tree | 4 studies | 22% ± 9% | |
| dendritic cell | 4 studies | 22% ± 5% | |
| myofibroblast cell | 4 studies | 21% ± 6% | |
| CD4-positive, alpha-beta T cell | 3 studies | 24% ± 11% | |
| hematopoietic precursor cell | 3 studies | 20% ± 5% | |
| naive thymus-derived CD8-positive, alpha-beta T cell | 3 studies | 16% ± 1% | |
| lymphocyte | 3 studies | 24% ± 2% | |
| myeloid cell | 3 studies | 22% ± 5% | |
| retinal rod cell | 3 studies | 37% ± 9% | |
| hepatocyte | 3 studies | 37% ± 28% | |
| muscle cell | 3 studies | 26% ± 8% | |
| connective tissue cell | 3 studies | 19% ± 3% | |
| intestinal crypt stem cell | 3 studies | 22% ± 6% | |
| club cell | 3 studies | 26% ± 4% | |
| respiratory goblet cell | 3 studies | 24% ± 9% | |
| monocyte | 3 studies | 17% ± 1% | |
| transit amplifying cell | 3 studies | 32% ± 16% | |
| granule cell | 3 studies | 26% ± 6% | |
| CD8-positive, alpha-beta T cell | 3 studies | 27% ± 8% | |
| mast cell | 3 studies | 16% ± 1% | |
| natural killer cell | 3 studies | 22% ± 6% |
